Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8845704 Visible light modulation of mitochondrial function in hypoxia and disease

Patent 8845704 was granted and assigned to Clarimedix on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88457040

Patent Inventor Names

Robert O. Poyton0

Richard Samuel Murdoch0

Vivian Dullien0

John Dunning0

Date of Patent

September 30, 2014

Patent Application Number

138466320

Date Filed

March 18, 2013

Patent Citations Received

‌

US Patent 12115384 Devices and methods for illuminating tissue to induce biological effects

‌

US Patent 11712578 Illumination devices for inducing biological effects

‌

US Patent 11752359 Illumination devices for inducing biological effects

‌

US Patent 11975215 Devices and related methods for phototherapeutic treatment of skin

‌

US Patent 11986666 Illumination devices for inducing biological effects

‌

US Patent 11998758 Phototherapeutic light for treatment of pathogens

‌

US Patent 12011611 Illumination devices for inducing biological effects

‌

US Patent 12109429 Phototherapeutic light for treatment of pathogens

...

Patent Primary Examiner

‌

Bill Thomson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8845704 Visible light modulation of mitochondrial function in hypoxia and disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API